23 November 2017
News and Views
Links and Services
This week‘s issue of the New England Journal of Medicine evaluates the use of sorafenib in advanced hepatocellular carcinoma.
No effective systemic therapy exists for patients with advanced hepatocellular carcinoma.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors